voice search
Boc-3-hydroxy-1-adamantyl-d-glycine
Share

Boc-3-hydroxy-1-adamantyl-d-glycine

Price:

Get Latest Price

In Stock

In Stock

Product Specifications

CAS No.361442-00-4
Molecular FormulaC17H27NO5
Molecular Weight325.40
Density1.296 g/cm³
Purity>98%
Packaging1g, 5g, 10g
UsagePharmaceutical research, peptide synthesis, drug discovery
FeaturesHigh purity, Custom synthesis, Research grade, Versatile building block, Pharmaceutical intermediate

Product Overview

Key Features

Being a very eminent name of the market, we are producing and exporting of Boc-3-Hydroxy-1-Adamantyl-D-Glycine to our esteemed patrons with the following information:
CAS No.: 361442-00-4
Molecular Formula: C17H27NO5
Molecular Weight: 325.40
Density: 1.296

Company Details

Shanghai Pansopharm Technology Co., Ltd., Registered in 2015 at Shanghai in Shanghai, is a leading Exporter,Manufacturer of Organic Intermediate in China. Shanghai Pansopharm Technology Co., Ltd. is one of Trade India's verified and trusted sellers of listed products. With extensive experience in supplying and trading Boc-3-Hydroxy-1-Adamantyl-D-Glycine, Shanghai Pansopharm Technology Co., Ltd. has made a reputed name for itself in the market with high-quality (1R,2S)-Rel-2-(3,4-Difluorophenyl) Cyclopropanamine Hydrochloride, (1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo[3.1.0]Hexane-2-Carboxylic Acid Tert-Butyl Ester, (2R,4S)-4-Amino-5-(Biphenyl-4-Yl)-2-Methylpentanoic Acid Ethyl Ester Hydrochloride, etc.
Focusing on a customer-centric approach, Shanghai Pansopharm Technology Co., Ltd. has a pan-India presence and caters to a huge consumer base throughout the country. Buy Organic Intermediate in bulk from Shanghai Pansopharm Technology Co., Ltd. at Trade India quality-assured products.

Business Type

Exporter, Manufacturer

Related Products

Explore Related Categories

More Product From This seller

Seller Details

Shanghai, Shanghai

Mrs. Maggie Wang

Address

Floor 2, Bldg. 7, No. 333, East Kangqiao Rd., Pudong, Shanghai, Shanghai, 201318, China

glycine in Shanghai

Report incorrect details